Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
about
Molecular underpinnings of corneal angiogenesis: advances over the past decadeMolecular testing in lung cancer in the era of precision medicineReceptor tyrosine kinase-mediated angiogenesisMouse models for studying angiogenesis and lymphangiogenesis in cancerInhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasisPI3K/PTEN signaling in angiogenesis and tumorigenesisAdenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.Neostatin-7 regulates bFGF-induced corneal lymphangiogenesisOverexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axisPhage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model.Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development.Lymphangiogenesis and lymphatic metastasis in breast cancer.Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathwayCurrent views on the function of the lymphatic vasculature in health and diseaseLysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma.VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner.Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formationCryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathwaysVEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library.Tumor lymphangiogenesis as a potential therapeutic target.Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesisInterleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.Lymphangiogenesis and cancerVascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastasesPharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosisThe role of VEGF receptors in angiogenesis; complex partnershipsTargeting lymphangiogenesis to prevent tumour metastasisRASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma.The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.OCT-based label-free in vivo lymphangiography within human skin and areolaVascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.
P2860
Q26747539-E1411D83-BAFD-4209-8EB9-653CB23EBDCEQ26824599-29437839-3CE7-484B-AF33-3E8A1041C137Q27001612-F972128C-696B-4468-B491-7C54CA8D7605Q27003898-8F10CFE0-1A7E-42D8-AED4-DA21718132ECQ27311384-8D055B6F-B3F8-4F36-832A-A271F88C2394Q28383083-41D4EA3B-4221-4E0C-AE39-6B42ECEC74FBQ30492895-CC39CEC1-E6BC-40A2-8D08-A3445E28DDF1Q33345623-DD916B49-D08E-4D50-832C-2193410BA075Q33509896-B88628A8-809B-4C85-B248-DBF5F02A95D0Q33565805-174FC355-75C6-42CB-AF1C-95C4A63ED7CDQ33651167-F108274D-5C58-4719-8B37-8517BB07EA89Q33737146-9D6FC959-0538-4670-AEBA-E60A66527BE8Q33795240-A313A7F7-4B29-420B-BE1E-985774529A9FQ33815773-777CD7C5-E199-4A76-9A63-46542D0E98E0Q33940058-1D5010A3-1288-4DAB-BF2D-E13FD1045835Q34003819-D1C29066-23DB-4D38-B485-F690783B3D28Q34164880-A1C75D27-BCD2-4F0D-B1B9-AA2D68A00C0CQ34387665-7A7C11F7-FF67-404C-B480-5AAFC10C5060Q34600828-33F13DE6-463B-4E68-B344-9840D96061F5Q34826155-8B5B2DD3-CC1D-40F5-B7D2-2279ADC48A83Q35142268-16DE2436-AE0D-4FF8-9247-12F4319651BEQ35166329-5383DC98-E859-4675-8295-07A6E9DCBF9FQ35402464-E0E87800-4130-4833-9F8A-93082EA7D440Q35501362-1EC34253-EC3A-4D08-9335-A8241E13A01AQ35597013-2CD35EFD-1360-4470-895D-493F5EC3A26BQ35616124-660C7FC5-7C8B-464E-B77D-D922B0D1EB9AQ35703718-222D3055-A879-4A0C-9715-9206B6B4ED03Q35838122-BB023B4A-F641-46B6-9540-7134762C1FF5Q35882208-82B84BC7-118A-40BA-9EB3-62135D3F790EQ35995835-C0F58B2B-DAED-44BB-9DA2-D970A7CA19C4Q36068960-62E806AA-C7A7-4028-A8AA-53F3D9F4484FQ36137692-CF6FBCF5-DA29-4CC6-B2F9-469344CEA39BQ36288143-536F9C02-AF6F-435A-A5BF-137D976A5DFAQ36382124-297D1EBB-05D4-4AB4-A960-AB13BAB6EBC4Q36390431-3F96DFC9-6520-42C3-902C-9702ED5DEB77Q36461582-E6EC0A2F-E85C-4151-9601-DEE79ACCD764Q36544139-FAEBDE3C-4F1A-419D-B3D6-B5CA8AD2A988Q36589860-BA0A8722-C43E-4F7B-AFD5-6CCEC253A1F6Q36595892-97985228-AC8A-488F-A95C-525C5911C6FEQ36749531-DF422E89-559D-4F14-95FA-642CDFB169E9
P2860
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibition of lymphogenous met ...... oluble VEGFR-3 decoy receptor.
@en
type
label
Inhibition of lymphogenous met ...... oluble VEGFR-3 decoy receptor.
@en
prefLabel
Inhibition of lymphogenous met ...... oluble VEGFR-3 decoy receptor.
@en
P2093
P1433
P1476
Inhibition of lymphogenous met ...... oluble VEGFR-3 decoy receptor.
@en
P2093
Alshad S Lalani
Guang Huan Tu
JianMin Lin
Karin Jooss
Kathryn Koprivnikar
Melinda J VanRoey
Melissa Gonzalez
Thomas C Harding
Wei-Wei Wu
P304
P356
10.1158/0008-5472.CAN-05-0408
P407
P577
2005-08-01T00:00:00Z